Skip to main content

ExodusPoint Capital Management, LP

Position in ADPT — Adaptive Biotechnologies Corp

CIK 1736225 NEW YORK, NY

Position in ADPT

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$7,703,677
+$6,223,722 QoQ
Shares Held
555,020
+124.8% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ADPT Over Time

Shares Held

Position Value (USD)

Derivatives in ADPT

reported options exposure · as of Sep 30, 2020
CallValue
$734,313
CallShares
15,100
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ExodusPoint Capital Management, LP holds $77,228,781 across 7 Diagnostics & Research names. ADPT ranks #4 (10.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ADPT
Adaptive Biotechnologies Corp
This page
555,020 $7,703,677

All Filings in ADPT

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,703,677 555,020
2024-12-31 $1,479,955 246,865
2023-12-31 $3,743,036 763,885
2023-09-30 $4,769,158 875,075
2023-06-30 $941,225 140,272
2023-03-31 $249,041 28,204
2022-12-31 $695,369 91,017
2022-09-30 $2,460,415 345,564
2022-06-30 $301,854 37,312
2022-03-31 $2,869,912 206,766
2021-12-31 $361,328 12,877
2020-12-31 $641,146 10,843
2020-09-30 $734,313 15,100
2020-09-30 $589,103 12,114
2020-06-30 $4,088,884 84,516
2020-06-30 $1,132,092 23,400